Difference between revisions of "HIV trials in Africa"
Jump to navigation
Jump to search
m (added template:RCT Auvert et al 2005) |
m (added African states) |
||
| Line 1: | Line 1: | ||
In 2007, three randomized controlled trials (RCTs) were carried out in Africa in an attempt to prove a hypothesis of certain [[circumcision advocate|circumcision promoters]] despite the known [[Immunological and protective function of the foreskin| immunological functions]] of the [[foreskin]], to link HIV infection to lack of [[circumcision]]. | In 2007, three randomized controlled trials (RCTs) were carried out in Africa in an attempt to prove a hypothesis of certain [[circumcision advocate|circumcision promoters]] despite the known [[Immunological and protective function of the foreskin| immunological functions]] of the [[foreskin]], to link HIV infection to lack of [[circumcision]]. | ||
| − | These trials | + | These trials were carried out in |
| − | + | * South Africa: | |
| − | * {{RCT Bailey et al 2007}} | + | : {{RCT Auvert et al 2005}} |
| − | * {{RCT Gray et al 2007}} | + | * Kenya: |
| + | : {{RCT Bailey et al 2007}} | ||
| + | * Uganda: | ||
| + | : {{RCT Gray et al 2007}} | ||
== Refutation == | == Refutation == | ||
| Line 63: | Line 66: | ||
[[Category:Flawed study]] | [[Category:Flawed study]] | ||
[[Category:Africa]] | [[Category:Africa]] | ||
| + | [[Category:Kenya]] | ||
| + | [[Category:South Africa]] | ||
| + | [[Category:Uganda]] | ||
Revision as of 09:57, 31 December 2021
In 2007, three randomized controlled trials (RCTs) were carried out in Africa in an attempt to prove a hypothesis of certain circumcision promoters despite the known immunological functions of the foreskin, to link HIV infection to lack of circumcision.
These trials were carried out in
- South Africa:
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial. PLoS Med. 25 October 2005; 2(11): e298. Retrieved 31 December 2021.
- Kenya:
- Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet. 24 February 2007; 369(9562): 643–56. PMID. DOI. Retrieved 31 December 2021.
- Uganda:
- Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet. 24 February 2007; 369(9562): 657-66. PMID. DOI. Retrieved 31 December 2021.
Refutation
Green et al. (2008), in a preliminary report, published a long list of methodological issues with the RCTs.[1]
Boyle & Hill (2011) studied their reports and found disabling methodological and statistical errors that invalidated their purported findings.[2]
Van Howe & Boyle (2018) further elaborated on these findings and suggested possible coordination between the RCTs and hinted at the possibility of fraud.[3]
References
- ↑ Green LW, McAllister RS, Peterson KW, Travis JR. Male circumcision is not the HIV ‘vaccine’ we have been waiting for!. Future HIV Therapy. 2008; 2(3): 193-9. DOI. Retrieved 29 November 2021.
- ↑ Boyle GJ, Hill G. Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns
. Thompson Reuter. December 2011; 19(2): 316-34. PMID. Retrieved 30 December 2020.
- ↑ Van Howe RS, Boyle GJ. Meta-analysis of HIV-acquisition studies incomplete and unstable. BJU Int. 31 October 2018; Retrieved 24 November 2021.
Quote:Given the effectiveness of condoms, the lack of consistent findings on national levels, the methodologically flawed RCTs, the lack of translational research, and the impressive potential uptake and effectiveness of pre-exposure prophylaxis, circumcision as an intervention to prevent HIV infection should be treated with greater scepticism.
